Results 131 to 140 of about 4,864,231 (177)

Refsum disease, peroxisomes and phytanic acid oxidation: a review.

open access: yesJournal of Neuropathology and Experimental Neurology, 2001
Refsum disease was first recognized as a distinct disease entity by Sigvald Refsum in the 1940s. The discovery of markedly elevated levels of the branched-chain fatty acid phytanic acid in certain patients marked Refsum disease as a disorder of lipid ...
Ronald Wanders   +2 more
exaly   +2 more sources

Molecular basis of Refsum disease: Sequence variations in Phytanoyl-CoA Hydroxylase (PHYH) and the PTS2 receptor (PEX7)†

open access: yesHuman Mutation, 2004
Refsum disease has long been known to be an inherited disorder of lipid metabolism characterized by the accumulation of phytanic acid (3,7,11,15-tetramethylhexadecanoic acid) caused by an alpha-oxidation deficiency of this branched chain fatty acid in ...
Hans R Waterham   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Cascade filtration in Refsum's disease

Nephrology Dialysis Transplantation, 1995
J B, Siegmund   +3 more
openaire   +4 more sources

Hypokalaemia in Acute Refsum's Disease

Journal of the Royal Society of Medicine, 1993
J P, Dick   +3 more
openaire   +4 more sources

Refsum's Disease and Refsum's Syndrome

Acta geneticae medicae et gemellologiae, 1974
Three observations of heredopathia atactica polyneuritiformis are reported. Two of these correspond to cases of Refsum's disease, though showing a very different evolution. The third one also seems to be a case of Refsum's syndrome, though showing different contradictory clinical and biochemical features.
openaire   +1 more source

Hepatic peroxisomes are deficient in infantile refsum disease: A cytochemical study of 4 cases

open access: yesAmerican Journal of Medical Genetics, Part A, 1986
We examined liver biopsies from 4 patients with the infantile form of Refsum disease. No peroxisomes were visualized by light microscopy after cytochemical staining for catalase, a marker enzyme for this organelle. Absence of peroxisomes was confirmed by
Patrick Aubourg, Frank Roels, H Ogier
exaly   +2 more sources

Refsum’s Disease

1989
Refsum’s disease (RD), also called heredopathia atactica polyneuritiformis, is a rare disorder with an autosomal recessive mode of inheritance, characterized by accumulation of phytanic acid. The age at onset is known to vary from early childhood to the fifth decade. The onset is insidious and may be difficult to determine precisely. Symptoms sometimes
Jacob Valk, Marjo S. van der Knaap
openaire   +1 more source

[Refsum disease].

La Revue de medecine interne, 1996
Refsum's disease, firstly described almost 50 years ago by the Norvegian neurologist Sigvald Refsum, is an autosomic recessive disease affecting mostly the Scandinavians and the populations originating from Northern Europe. The disease results from a specific enzyme deficiency of the first step of phytanic acid catabolism pathway. This deficiency leads
I, Hochner, J F, Blickle, J M, Brogard
openaire   +1 more source

[Refsum disease].

Orvosi hetilap, 2000
For the first time in literature the authors interpret the pathography of Refsum's disease, in the case of their patient, as pseudo-hypervitaminosis A. The biochemical basis of the clinical picture is a defect in the activity of phytanic-acid-alpha-hydrolase belonging to the peroxisomal system.
G, Bernscherer   +6 more
openaire   +1 more source

Skeletal changes in Refsum's disease

Clinical Radiology, 1979
Refsum's disease is a rare inherited disease of lipid metabolism. The cardinal diagnostic features include polyneuritis, cerebellar ataxia, an atypical pigmentosa and a high CSF protein. The disorders is accompanied by the accumulation in the tissues, especially the liver and kidneys, of the lipid 'phytanic acid'.
W J, Wall, B S, Worthington
openaire   +2 more sources

Home - About - Disclaimer - Privacy